4.7 Review

The role of the kidney in heart failure

期刊

EUROPEAN HEART JOURNAL
卷 33, 期 17, 页码 2135-+

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehs205

关键词

Heart failure; Chronic kidney disease; Cardio-renal syndrome; Acute kidney injury

资金

  1. Abbott Vascular
  2. Bayer
  3. Corthera
  4. Novartis
  5. Thoratec
  6. Novacardia
  7. Merck
  8. Nile
  9. Celadon
  10. BioHeart
  11. Cardio 3
  12. Amgen
  13. Trevena
  14. Annexon
  15. NIH
  16. Bayer Schering Pharma AG [10,000]
  17. DebioPharm S.A.
  18. Medtronic
  19. Novartis Pharma AG
  20. Otsuka Pharmaceuticals
  21. Sigma Tau
  22. Solvay Pharmaceuticals
  23. Sticares InterACT
  24. Takeda Pharmaceuticals North America, Inc.
  25. Alere

向作者/读者索取更多资源

Renal dysfunction is common in patients with heart failure and is associated with high morbidity and mortality. Cardiac and renal dysfunction may worsen each other through multiple mechanisms such as fluid overload and increased venous pressure, hypo-perfusion, neurohormonal and inflammatory activation, and concomitant treatment. The interaction between cardiac and renal dysfunction may be critical for disease progression and prognosis. Renal dysfunction is conventionally defined by a reduced glomerular filtration rate, calculated from serum creatinine levels. This definition has limitations as serum creatinine is dependent on age, gender, muscle mass, volume status, and renal haemodynamics. Changes in serum creatinine related to treatment with diuretics or angiotensin-converting enzyme inhibitors are not necessarily associated with worse outcomes. New biomarkers might be of additional value to detect an early deterioration in renal function and to improve the prognostic assessment, but they need further validation. Thus, the evaluation of renal function in patients with heart failure is important as it may reflect their haemodynamic status and provide a better prognostic assessment. The prevention of renal dysfunction with new therapies might also improve outcomes although strong evidence is still lacking.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据